Cost–utility of sentinel lymph node biopsy in cT1–T2N0 oral cancer

Highlights • From a 5 or 10-year time horizon, SLNB is the most cost-effective strategy. • From a lifetime horizon, END is the most cost-effective strategy. • Improving sensitivity of SLNB will make it the best strategy from all time horizons.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oral oncology 2016-02, Vol.53, p.20-26
Hauptverfasser:	van der Linden, Naomi, Flach, Géke B, de Bree, Remco, Uyl-de Groot, Carin A
Format:	Artikel
Sprache:	eng
Schlagworte:	Cost-Benefit Analysis Decision support techniques Decision trees Endoscopic Ultrasound-Guided Fine Needle Aspiration - economics Fine-needle biopsy Hematology, Oncology and Palliative Medicine Humans Lymph Nodes - pathology Lymphatic Metastasis - pathology Markov chains Mouth neoplasms Mouth Neoplasms - economics Mouth Neoplasms - pathology Neck Neck dissection Neck Dissection - economics Netherlands Otolaryngology Quality-Adjusted Life Years Sentinel lymph node biopsy Sentinel Lymph Node Biopsy - economics Surveys and Questionnaires
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • From a 5 or 10-year time horizon, SLNB is the most cost-effective strategy. • From a lifetime horizon, END is the most cost-effective strategy. • Improving sensitivity of SLNB will make it the best strategy from all time horizons.
ISSN:	1368-8375 1879-0593
DOI:	10.1016/j.oraloncology.2015.11.011